SOLIRIS Side Effects

7017975-7 | Biopsy Kidney, Haematuria, Post Procedural Complication
on Sep 27, 2010 Female patient from UNITED STATES , weighting 153.0 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy kidney, haematuria, post procedural complication. Soliris dosage: 1200 Mg Once Iv. Patient was hospitalized.

7010833-3 | Blood Culture Positive, Blood Pressure Decreased, Cardiac Disorder, Complications Of Transplanted Kidney, Culture Urine Positive, Dyspnoea, Enterococcal Infection, Ileus, Renal Tubular Necrosis
Patient was taking Soliris (View Usage). Patient had the following side effects: blood culture positive, blood pressure decreased, cardiac disorder, complications of transplanted kidney, culture urine positive, dyspnoea, enterococcal infection, ileus, renal tubular necrosis on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 210.5 lb, was diagnosed with prophylaxis against transplant rejection and. Soliris dosage: 1200 Mg Once Iv 900 Mg Fifteen Iv. Patient was hospitalized.

7009360-9 | Abdominal Discomfort, Colon Cancer Recurrent, Dizziness, Headache, Nausea
Adverse event was reported on Sep 15, 2010 by a Female patient taking Soliris (View Usage) (Dosage: 600 Mg, Qw) was diagnosed with paroxysmal nocturnal haemoglobinuria, pain (What is pain?) and. Location: UNITED STATES , weighting 204.0 lb, After Soliris was administered, patient had the following side effects: abdominal discomfort, colon cancer recurrent, dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?). During the same period patient was treated with TYLENOL (CAPLET) (1000 Mg, Unk) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), BENTYL (20 Mg, Prn) (View Bentyl Review and Bentyl Label ), METOPROLOL TARTRATE (25 Mg, Bid) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CELEBREX (Prn) (View Celebrex Review and Celebrex Label ).

7006625-1 | Lower Respiratory Tract Infection, Migraine, Paratracheal Lymphadenopathy, Procedural Complication
on Sep 21, 2010 Female patient from UNITED STATES , 48 years of age, weighting 176.4 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: lower respiratory tract infection, migraine (What is migraine?), paratracheal lymphadenopathy, procedural complication. Soliris dosage: 600 Mg 5 Iv 2/18, 2/24-3/17/10 Weekly 1200 Mg 13 Iv 2/17, 2/25-9/8 Once Every 2 Wks. Patient was hospitalized.


6957761-7 | Haemodialysis, Haemolytic Anaemia, Hypotension, Metabolic Acidosis, Multi-organ Failure, Odynophagia, Pancytopenia, Renal Failure Acute, Respiratory Failure
on Aug 23, 2010 Male patient from BRAZIL , 65 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient had the following side effects: haemodialysis, haemolytic anaemia, hypotension, metabolic acidosis, multi-organ failure, odynophagia, pancytopenia, renal failure acute, respiratory failure. Soliris dosage: 900 Mg, Unk. Patient was hospitalized.

6957760-5 | Haemolysis, Herpes Zoster
Patient was taking Soliris (View Usage). After Soliris was administered, patient had the following side effects: haemolysis, herpes zoster on Aug 19, 2010 from JAPAN Additional patient health information: Male patient , 42 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Qw. During the same period patient was treated with PURIMBORAN (15 Mg, Qd) (View Purimboran Review and Purimboran Label ), PSL (10 Mg, Qd) (View Psl Review and Psl Label ), BLOOD AND RELATED PRODUCTS (Unk) (View Blood And Related Products Review and Blood And Related Products Label ). Patient was hospitalized.

6955511-1 | Abdominal Pain Lower, Ascites, Dyspnoea, Electrocardiogram T Wave Peaked, Hyperkalaemia, Kidney Transplant Rejection
Adverse event was reported on Aug 26, 2010 by a Female patient taking Soliris (View Usage) (Dosage: 1200 Mg Once Iv ; 900 Mg 13 Doses Iv) was diagnosed with prophylaxis against transplant rejection and. Location: UNITED STATES , weighting 151.5 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain lower, ascites, dyspnoea, electrocardiogram t wave peaked, hyperkalaemia, kidney transplant rejection. Patient was hospitalized.

6955105-8 | Blood Bilirubin Increased, Haemolysis, Infection, Muscle Haemorrhage
on Aug 19, 2010 Male patient from JAPAN , 64 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient had the following side effects: blood bilirubin increased, haemolysis, infection (What is infection?), muscle haemorrhage. Soliris dosage: 900 Mg, Q2w. During the same period patient was treated with WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), URSODIOL (100 Mg, Unk) (View Ursodiol Review and Ursodiol Label ), RABEPRAZOLE SODIUM (10 Mg, Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BROTIZOLAM (0.25 Mg, Unk) (View Brotizolam Review and Brotizolam Label ), LEVOFLOXACIN (500 Mg, Unk) (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6944748-3 | Haemolytic Anaemia, Odynophagia, Pancytopenia, Sepsis, Urosepsis
on Aug 16, 2010 Male patient from BRAZIL , 65 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: haemolytic anaemia, odynophagia, pancytopenia, sepsis (What is sepsis?), urosepsis. Soliris dosage: 900 Mg, Unk. Patient was hospitalized.

6930028-9 | Haemolysis, Sepsis, Urosepsis
Patient was taking Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: haemolysis, sepsis (What is sepsis?), urosepsis on Aug 05, 2010 from BRAZIL Additional patient health information: Male patient , 65 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 900 Mg, Unk. Patient was hospitalized.

6922781-5 | Blood Bilirubin Increased, Haemolysis, Infection, Muscle Haemorrhage
Adverse event was reported on Aug 04, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 900 Mg, Q2w) was diagnosed with paroxysmal nocturnal haemoglobinuria and. Location: JAPAN , 64 years of age, Patient had the following side effects: blood bilirubin increased, haemolysis, infection (What is infection?), muscle haemorrhage. During the same period patient was treated with WARFARIN (Unk) (View Warfarin Review and Warfarin Label ), URSODIOL (100 Mg, Unk) (View Ursodiol Review and Ursodiol Label ), RABEPRAZOLE SODIUM (10 Mg, Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BROTIZOLAM (0.25 Mg, Unk) (View Brotizolam Review and Brotizolam Label ), LEVOFLOXACIN (500 Mg, Unk) (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6920858-1 | Presyncope, White Blood Cell Count Increased
on Aug 03, 2010 Female patient from UNITED STATES , 27 years of age, weighting 229.3 lb, was diagnosed with haemolytic uraemic syndrome and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: presyncope, white blood cell count increased. Soliris dosage: 900 Mg, Single. During the same period patient was treated with LASIX (40 Mg, Bid) (View Lasix Review and Lasix Label ), PREDNISONE TAB (30 Mg, Unk) (View Prednisone Tab Review and Prednisone Tab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ALDACTONE (25 Mg, Unk) (View Aldactone Review and Aldactone Label ), LOVENOX (100 Mg, Unk) (View Lovenox Review and Lovenox Label ).

6919031-2 | Thyroid Cancer
on Aug 03, 2010 Female patient from UNITED STATES , weighting 252.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: thyroid cancer (What is thyroid cancer?). Soliris dosage: 600 Mg, Qw X 4 Weeks. During the same period patient was treated with METFORMIN HCL (500 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), ALLOPURINOL (100 Mg, Bid) (View Allopurinol Review and Allopurinol Label ), ALENDRONATE SODIUM (70 Mg, Qw) (View Alendronate Sodium Review and Alendronate Sodium Label ), ENALAPRIL MALEATE (10 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), HYDROCHLOROTHIAZIDE (25 Mg, Bid) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL (50 Mg, Bid) (View Metoprolol Review and Metoprolol Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

6907926-5 | Haemolysis, Herpes Zoster
Patient was taking Soliris (View Usage). Patient had the following side effects: haemolysis, herpes zoster on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 42 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Qw. Patient was hospitalized.

6905568-9 | Abdominal Abscess, Dyspepsia, Fatigue, Incisional Hernia, Lung Infiltration, Nausea, Post Procedural Haematoma, Renal Failure Acute, Sepsis
Adverse event was reported on Jul 20, 2010 by a Female patient taking Soliris (View Usage) (Dosage: 600 Mg, Qw) was diagnosed with paroxysmal nocturnal haemoglobinuria and. Location: UNITED STATES , weighting 94.68 lb, After Soliris was administered, patient had the following side effects: abdominal abscess, dyspepsia, fatigue, incisional hernia, lung infiltration, nausea (What is nausea?), post procedural haematoma, renal failure acute, sepsis (What is sepsis?). During the same period patient was treated with MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), PROGRAF (Unk) (View Prograf Review and Prograf Label ), URSODIOL (Unk) (View Ursodiol Review and Ursodiol Label ), LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ), COLACE (Unk) (View Colace Review and Colace Label ), COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), PROTONIX (Unk) (View Protonix Review and Protonix Label ). Patient was hospitalized.

6899871-9 | Haemolysis
on Jul 20, 2010 Male patient from JAPAN , 64 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: haemolysis. Soliris dosage: 900 Mg, Q2w. Patient was hospitalized.

6894654-8 | Acute Myeloid Leukaemia
on Jul 20, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient had the following side effects: acute myeloid leukaemia. Soliris dosage: Unk.

6882435-0 | Hypoglycaemia, Post Procedural Complication, Small Intestinal Obstruction
Patient was taking Soliris (View Usage). After Soliris was administered, patient had the following side effects: hypoglycaemia, post procedural complication, small intestinal obstruction on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 93.04 lb, was diagnosed with prophylaxis against transplant rejection and. Soliris dosage: 1200 Mg Once Iv ; 900 Mg Once Iv. Patient was hospitalized.

6880751-X | Thyroid Cancer
Adverse event was reported on Jul 20, 2010 by a Female patient taking Soliris (View Usage) (Dosage: 600 Mg, Qw X 4 Weeks) was diagnosed with paroxysmal nocturnal haemoglobinuria and. Location: UNITED STATES , weighting 252.0 lb, Patient experienced the following unwanted or unexpected effects: thyroid cancer (What is thyroid cancer?). During the same period patient was treated with METFORMIN HCL (500 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), ALLOPURINOL (100 Mg, Bid) (View Allopurinol Review and Allopurinol Label ), ALENDRONATE SODIUM (70 Mg, Qw) (View Alendronate Sodium Review and Alendronate Sodium Label ), ENALAPRIL MALEATE (10 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), HYDROCHLOROTHIAZIDE (25 Mg, Bid) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL TARTRATE (50 Mg, Bid) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

6875938-6 | Blood Lactate Dehydrogenase Increased, Cholangitis, Cholecystitis Acute, Cholelithiasis, Nephrolithiasis
on Jul 19, 2010 Female patient from UNITED STATES , weighting 116.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria, hypogammaglobulinaemia and was treated with Soliris (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, cholangitis, cholecystitis acute, cholelithiasis, nephrolithiasis. Soliris dosage: Unk. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (Q4-6w) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), TRAZODONE (50 Mg, Qd, Hs) (View Trazodone Review and Trazodone Label ). Patient was hospitalized.

6785953-9 | Abdominal Pain, Acute Disseminated Encephalomyelitis, Pulmonary Haemorrhage, Respiratory Failure, Urinary Tract Infection
on Jun 17, 2010 Male patient from UNITED STATES , weighting 36.16 lb, was diagnosed with haemolytic uraemic syndrome, constipation (What is constipation?), blood pressure management and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), acute disseminated encephalomyelitis, pulmonary haemorrhage, respiratory failure, urinary tract infection (What is urinary tract infection?). Soliris dosage: 300 Mg, Q10-28 Days. During the same period patient was treated with KLONOPIN (0.125 Mg, Qd (qhs)) (View Klonopin Review and Klonopin Label ), CALCIUM CARBONATE (250 Mg, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), MYLICON (40 Mg, Qid, Prn) (View Mylicon Review and Mylicon Label ), COLACE (20 Mg, Qd (qhs) Prn) (View Colace Review and Colace Label ), VASOTEC (0.5 Mg, Q12h Prn) (View Vasotec Review and Vasotec Label ), PREVACID (15 Mg, Qd) (View Prevacid Review and Prevacid Label ), POTASSIUM CHLORIDE (5.32 Meq, Bid During Gt Feed) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6781659-0 | Blood Lactate Dehydrogenase Increased, Cholangitis, Cholecystitis Acute, Cholelithiasis, Nephrolithiasis
Patient was taking Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, cholangitis, cholecystitis acute, cholelithiasis, nephrolithiasis on Jun 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 116.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria, hypogammaglobulinaemia and. Soliris dosage: 900 Mg, Q2w. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (Q4-6w) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), TRAZODONE HYDROCHLORIDE (50 Mg, Qd, Hs) (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ). Patient was hospitalized.

6766713-1 | Abdominal Pain, Acute Disseminated Encephalomyelitis, Pulmonary Haemorrhage, Respiratory Failure, Urinary Tract Infection
Adverse event was reported on May 27, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 300 Mg, Q7-10 Days) was diagnosed with haemolytic uraemic syndrome, constipation (What is constipation?), blood pressure management and. Location: UNITED STATES , weighting 35.27 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), acute disseminated encephalomyelitis, pulmonary haemorrhage, respiratory failure, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with KLONOPIN (0.125 Mg, Qd (qhs)) (View Klonopin Review and Klonopin Label ), CALCIUM CARBONATE (250 Mg, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), MYLICON (40 Mg, Qid, Prn) (View Mylicon Review and Mylicon Label ), COLACE (20 Mg, Qd (qhs) Prn) (View Colace Review and Colace Label ), VASOTEC (0.5 Mg, Q12h Prn) (View Vasotec Review and Vasotec Label ), PREVACID (15 Mg, Qd) (View Prevacid Review and Prevacid Label ), POTASSIUM CHLORIDE (5.32 Meq, Bid During Gt Feed) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6762478-8 | Bacterial Sepsis, Haemoglobin Decreased
on Jun 02, 2010 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: bacterial sepsis, haemoglobin decreased. Soliris dosage: 600 Mg, Unk. During the same period patient was treated with AMBIEN (View Ambien Review and Ambien Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GLUCOSAMINE/CHONDROITIN /01625901/ (View Glucosamine/chondroitin /01625901/ Review and Glucosamine/chondroitin /01625901/ Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6757977-9 | Wound Dehiscence
on Jun 04, 2010 Female patient from UNITED STATES , weighting 113.8 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: wound dehiscence. Soliris dosage: 1200 Mg Once Iv 900 Mg Three Iv. Patient was hospitalized.

6749241-9 | Arthritis, Bacterial Sepsis, Chondrocalcinosis Pyrophosphate, Disseminated Intravascular Coagulation, Fibrin D Dimer Increased, Haemoglobin Decreased, Hyperglycaemia, Prothrombin Time Prolonged
Patient was taking Soliris (View Usage). Patient had the following side effects: arthritis (What is arthritis?), bacterial sepsis, chondrocalcinosis pyrophosphate, disseminated intravascular coagulation, fibrin d dimer increased, haemoglobin decreased, hyperglycaemia, prothrombin time prolonged on May 21, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Unk. Patient was hospitalized.

6727586-6 | Abdominal Pain, Nervous System Disorder, Pulmonary Haemorrhage, Respiratory Failure, Urinary Tract Infection
Adverse event was reported on May 06, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 300 Mg, Q7-10 Days) was diagnosed with haemolytic uraemic syndrome, constipation (What is constipation?), blood pressure management and. Location: UNITED STATES , weighting 35.27 lb, After Soliris was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), nervous system disorder, pulmonary haemorrhage, respiratory failure, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with KLONOPIN (0.125 Mg, Qd (qhs)) (View Klonopin Review and Klonopin Label ), CALCIUM CARBONATE (250 Mg, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), MYLICON (40 Mg, Qid, Prn) (View Mylicon Review and Mylicon Label ), COLACE (20 Mg, Qd (qhs) Prn) (View Colace Review and Colace Label ), VASOTEC (0.5 Mg, Q12h Prn) (View Vasotec Review and Vasotec Label ), PREVACID (15 Mg, Qd) (View Prevacid Review and Prevacid Label ), POTASSIUM CHLORIDE (5.32 Meq, Bid During Gt Feed) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6725756-4 | Atrial Fibrillation
on May 13, 2010 Female patient from UNITED STATES , weighting 113.3 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Soliris dosage: 1200 Mg Once Iv. Patient was hospitalized.

6714008-4 | Arthritis, Bacterial Sepsis, Chondrocalcinosis Pyrophosphate, Disseminated Intravascular Coagulation, Fibrin D Dimer Increased, Haemoglobin Decreased, Hyperglycaemia, Prothrombin Time Prolonged
on Apr 28, 2010 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient had the following side effects: arthritis (What is arthritis?), bacterial sepsis, chondrocalcinosis pyrophosphate, disseminated intravascular coagulation, fibrin d dimer increased, haemoglobin decreased, hyperglycaemia, prothrombin time prolonged. Soliris dosage: 600 Mg, Unk. Patient was hospitalized.

6707022-6 | Atrial Flutter, Blood Creatinine Increased, Device Dislocation, Diarrhoea, Hydronephrosis, Oesophageal Candidiasis, Oesophagitis Ulcerative, Pyrexia
Patient was taking Soliris (View Usage). After Soliris was administered, patient had the following side effects: atrial flutter, blood creatinine increased, device dislocation, diarrhoea, hydronephrosis, oesophageal candidiasis, oesophagitis ulcerative, pyrexia on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 209.4 lb, was diagnosed with prophylaxis against transplant rejection and. Soliris dosage: 1200 Mg Once Iv 600 Mg Once Iv. Patient was hospitalized.

6704158-0 | Abdominal Pain, Nervous System Disorder, Pulmonary Haemorrhage, Respiratory Failure, Urinary Tract Infection
Adverse event was reported on Apr 19, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 300 Mg, Q7-10 Days) was diagnosed with haemolytic uraemic syndrome, constipation (What is constipation?), blood pressure management and. Location: UNITED STATES , weighting 35.27 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), nervous system disorder, pulmonary haemorrhage, respiratory failure, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with KLONOPIN (0.125 Mg, Qd (qhs)) (View Klonopin Review and Klonopin Label ), CALCIUM CARBONATE (250 Mg, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), MYLICON (40 Mg, Qid, Prn) (View Mylicon Review and Mylicon Label ), COLACE (20 Mg, Qd (qhs) Prn) (View Colace Review and Colace Label ), VASOTEC (0.5 Mg, Q12h Prn) (View Vasotec Review and Vasotec Label ), PREVACID (15 Mg, Qd) (View Prevacid Review and Prevacid Label ), POTASSIUM CHLORIDE (5.32 Meq, Bid During Gt Feed) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6702331-9 | Atelectasis, Chills, Infection, Iron Overload, Pleural Effusion, Pulmonary Mass
on Apr 21, 2010 Male patient from UNITED STATES , weighting 163.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient had the following side effects: atelectasis, chills, infection (What is infection?), iron overload, pleural effusion, pulmonary mass. Soliris dosage: 600 Mg, Qw X4. During the same period patient was treated with POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), DILTIAZEM HCL (Unk) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), PREDNISONE (Tapered Dose) (View Prednisone Review and Prednisone Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), ZOLPIDEM (Unk) (View Zolpidem Review and Zolpidem Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ).

6695460-X | Hydronephrosis, Lymphocele, Oedema Peripheral
on Apr 22, 2010 Female patient from UNITED STATES , weighting 137.6 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: hydronephrosis, lymphocele, oedema peripheral. Soliris dosage: 1200 Mg Four Iv 600 Mg Nine Iv. Patient was hospitalized.

6687961-5 | Haemoglobin Decreased, Renal Impairment
Patient was taking Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, renal impairment on Apr 07, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 157.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Qw X4.

6682367-7 | Leukopenia
Adverse event was reported on Apr 02, 2010 by a Male patient taking Soliris (View Usage) (Dosage: Unk) was diagnosed with malignant atrophic papulosis and. Location: UNITED STATES , weighting 154.3 lb, Patient had the following side effects: leukopenia.

6678844-5 | Herpes Zoster Disseminated
on Apr 12, 2010 Female patient from UNITED STATES , weighting 168.4 lb, was diagnosed with haemolytic uraemic syndrome, prophylaxis against transplant rejection, thrombotic microangiopathy and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: herpes zoster disseminated. Soliris dosage: 1200mg Every 2 Wks Iv. During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), PROTONIX (View Protonix Review and Protonix Label ).

6677892-9 | Anaemia, Atelectasis, Device Related Infection, Oedema Peripheral, Pain, Transplant Rejection, Viral Infection, Vomiting
on Apr 06, 2010 Female patient from UNITED STATES , weighting 141.1 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria, immunosuppression, deep vein thrombosis (What is deep vein thrombosis?) and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, atelectasis, device related infection, oedema peripheral, pain (What is pain?), transplant rejection, viral infection (What is viral infection?), vomiting. Soliris dosage: 600 Mg, Qw X 4 Weeks. During the same period patient was treated with PROGRAFT (1 Mg, Qd) (View Prograft Review and Prograft Label ), COUMADIN (5 Mg, Qd) (View Coumadin Review and Coumadin Label ), PENICILLIN /00000901/ (500 Mg, Qd) (View Penicillin /00000901/ Review and Penicillin /00000901/ Label ), URSODIOL (300 Mg, Tid) (View Ursodiol Review and Ursodiol Label ), ZOLOFT (100 Mg, Qd) (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6677877-2 | Arthritis, Bacterial Sepsis, Chondrocalcinosis Pyrophosphate, Disseminated Intravascular Coagulation, Fibrin D Dimer Increased, Haemoglobin Decreased, Hyperglycaemia, Prothrombin Time Prolonged
Patient was taking Soliris (View Usage). Patient had the following side effects: arthritis (What is arthritis?), bacterial sepsis, chondrocalcinosis pyrophosphate, disseminated intravascular coagulation, fibrin d dimer increased, haemoglobin decreased, hyperglycaemia, prothrombin time prolonged on Apr 06, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Unk. Patient was hospitalized.

6677849-8 | Abdominal Pain, Back Pain, Chest Discomfort, Dehydration, Febrile Neutropenia, Feeling Abnormal, Flank Pain, Haemolysis
Adverse event was reported on Mar 12, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 600 Mg, Qw X 4 Weeks) was diagnosed with paroxysmal nocturnal haemoglobinuria, nausea (What is nausea?) and. Location: UNITED STATES , weighting 169.8 lb, After Soliris was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), chest discomfort, dehydration, febrile neutropenia, feeling abnormal, flank pain, haemolysis. During the same period patient was treated with AMLODIPINE (10 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), ATIVAN (1 Mg, Tid Prn) (View Ativan Review and Ativan Label ). Patient was hospitalized.

6677848-6 | Photodermatosis
on Mar 17, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: photodermatosis. Soliris dosage: Unk.

6677843-7 | Upper Respiratory Tract Infection
on Mar 29, 2010 Male patient from UNITED STATES , weighting 226.5 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient had the following side effects: upper respiratory tract infection. Soliris dosage: Unk. During the same period patient was treated with FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), IMMUNOSUPPRESSANTS (View Immunosuppressants Review and Immunosuppressants Label ).

6677773-0 | Haemoglobin Decreased
Patient was taking Soliris (View Usage). After Soliris was administered, patient had the following side effects: haemoglobin decreased on Feb 02, 2010 from CANADA Additional patient health information: Female patient , 62 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Weekly For Four Weeks. During the same period patient was treated with PANTAZOL (Unk) (View Pantazol Review and Pantazol Label ), PENTASA (View Pentasa Review and Pentasa Label ), CIPRALEX /01588501/ (View Cipralex /01588501/ Review and Cipralex /01588501/ Label ), IMOVANE (Unk) (View Imovane Review and Imovane Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ACTONEL (Unk) (View Actonel Review and Actonel Label ).

6677735-3 | Feeling Hot, Flushing, Nausea
Adverse event was reported on Feb 16, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 600 Mg, Unk) was diagnosed with paroxysmal nocturnal haemoglobinuria, pain (What is pain?) and. Location: UNITED STATES , weighting 168.0 lb, Patient experienced the following unwanted or unexpected effects: feeling hot, flushing, nausea (What is nausea?). During the same period patient was treated with ROXICET (Unk) (View Roxicet Review and Roxicet Label ).

6677732-8 | Anaemia, Bronchitis, Headache, Pneumonia
on Jan 26, 2010 Male patient from UNITED STATES , weighting 162.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria, bronchitis (What is bronchitis?) and was treated with Soliris (View Usage). Patient had the following side effects: anaemia, bronchitis (What is bronchitis?), headache (What is headache?), pneumonia (What is pneumonia?). Soliris dosage: 600 Mg, Qw X 4w. During the same period patient was treated with AUGMENTIN '125' (Unk) (View Augmentin '125' Review and Augmentin '125' Label ), TOPROL XL (Unk) (View Toprol-xl Review and Toprol-xl Label ), IRON (Unk) (View Iron Review and Iron Label ), COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), FIORICET (Unk) (View Fioricet Review and Fioricet Label ), MULTIVITAMIN /00831701/ (Unk) (View Multivitamin /00831701/ Review and Multivitamin /00831701/ Label ). Patient was hospitalized.

6677723-7 | Dysphagia, Dyspnoea, Musculoskeletal Chest Pain
on Jan 08, 2010 Male patient from UNITED STATES , weighting 195.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria, insomnia, pain (What is pain?) and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: dysphagia, dyspnoea, musculoskeletal chest pain. Soliris dosage: 600 Mg, Qw. During the same period patient was treated with AMBIEN (10 Mg, Qhs Prn) (View Ambien Review and Ambien Label ), CLARITIN /00917501/ (10 Mg, Qd) (View Claritin /00917501/ Review and Claritin /00917501/ Label ), COZAAR (100 Mg, Qd) (View Cozaar Review and Cozaar Label ), DILAUDID (Q4-6h 4 Mg, Prn) (View Dilaudid Review and Dilaudid Label ), DOCUSATE SODIUM (100 Mg, Bid) (View Docusate Sodium Review and Docusate Sodium Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ).

6677713-4 | Haemoglobin Decreased, Nasopharyngitis
Patient was taking Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, nasopharyngitis on Jan 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 150.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: 600 Mg, Qwk. During the same period patient was treated with FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), ANTRA /00661201/ (7.5 Mg, Qd) (View Antra /00661201/ Review and Antra /00661201/ Label ).

6677688-8 | Atelectasis, Chills, Infection, Iron Overload, Pleural Effusion, Pulmonary Mass
Adverse event was reported on Feb 25, 2010 by a Male patient taking Soliris (View Usage) (Dosage: 600 Mg, Qw X4) was diagnosed with paroxysmal nocturnal haemoglobinuria and. Location: UNITED STATES , weighting 163.0 lb, Patient had the following side effects: atelectasis, chills, infection (What is infection?), iron overload, pleural effusion, pulmonary mass. During the same period patient was treated with POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), DILTIAZEM HCL (Unk) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), PREDNISOLONE (Tapered Dose) (View Prednisolone Review and Prednisolone Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), ZOLPIDEM (Unk) (View Zolpidem Review and Zolpidem Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ).

6677641-4 | Abdominal Pain Upper, Blood Product Transfusion Dependent, Condition Aggravated, Cough, Fatigue, Vomiting
on Feb 09, 2010 Female patient from UNITED STATES , weighting 156.0 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). After Soliris was administered, patient had the following side effects: abdominal pain upper, blood product transfusion dependent, condition aggravated, cough, fatigue, vomiting. Soliris dosage: 600 Mg, Qw X4. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), HYDRALAZINE AND BENAZEPRIL (View Hydralazine And Benazepril Review and Hydralazine And Benazepril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), EXJADE (View Exjade Review and Exjade Label ). Patient was hospitalized.

6677606-2 | Dyspnoea Exertional, Neuropathy Peripheral, Rash, Serum Ferritin Increased
on Feb 19, 2010 Male patient from UNITED STATES , weighting 177.9 lb, was diagnosed with paroxysmal nocturnal haemoglobinuria and was treated with Soliris (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea exertional, neuropathy peripheral, rash (What is rash?), serum ferritin increased. Soliris dosage: 600 Mg, Qw. During the same period patient was treated with DESFERAL /00062903/ (4x/w) (View Desferal /00062903/ Review and Desferal /00062903/ Label ), ATIVAN (Unk) (View Ativan Review and Ativan Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM (Unk) (View Potassium Review and Potassium Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), VITAMIN B12 /00056201/ (Unk) (View Vitamin B12 /00056201/ Review and Vitamin B12 /00056201/ Label ), LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ).

6677597-4 | Abdominal Pain, Anaphylactic Reaction
Patient was taking Soliris (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaphylactic reaction on Feb 04, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with paroxysmal nocturnal haemoglobinuria and. Soliris dosage: Unk.